Verapamil is more potent than diltiazem and nifedipine in relaxing bovine coronary arteries and modulates vascular responses to key neurotransmitters.
Answers are grounded in this paper and cite their sources.
Bovine artery data should not alter clinical CCB use; leaves open human coronary translation.
Verapamil (0.05-5 microM), diltiazem (0.2-20 microM), and nifedipine (0.3-30 microM) produced concentration-dependent relaxation of bovine coronary artery. Based on the EC50 values (concentration to produce 50% maximum response), the calcium entry blocker verapamil (relative potency = 1) was 3.4 and 7 times as potent as diltiazem and nifedipine, respectively, in producing relaxation of bovine coronary artery. In addition, verapamil reduced the contractions produced by acetylcholine (0.01-10 microM), 5-hydroxytryptamine (5-HT) (0.01-10 microM) whereas it potentiated the relaxation produced by noradrenaline (0.01-10 microM). It was concluded that verapamil, diltiazem, and nifedipine (a) relax the bovine coronary artery, verapamil being more potent than diltiazem and nifedipine, and (b) the calcium entry blockers modified the contractile responses to neurotransmitter agents, acetylcholine, noradrenaline, and 5-HT, inhibiting the contractions produced by acetylcholine and 5-HT, and enhancing the relaxation produced by noradrenaline.
No takes yet. Share an insight, caveat, or question.
WALI et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: